| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.1462 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.1462 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.1462 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.1462 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.1462 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.1574 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.1602 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.1819 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.1837 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.1845 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.1874 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.2093 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.2423 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.2425 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.2478 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.2520 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.2529 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.2857 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.2870 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.2882 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.2885 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3002 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3114 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3329 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3355 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3368 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3596 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3653 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3746 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3797 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3828 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3895 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3923 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3949 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.3956 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4006 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4082 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4210 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4304 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4387 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4595 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4607 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4717 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4762 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4773 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4903 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.4931 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.5072 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.5157 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.5252 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.5373 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.5392 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.5503 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.5543 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.5647 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.5773 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.5924 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.6117 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.6139 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.6547 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.6810 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.6848 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.7005 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.7080 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.7416 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.7649 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.7795 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.7856 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8024 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8068 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8216 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8238 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8262 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8373 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8402 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8471 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8700 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8777 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8781 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8799 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8910 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8918 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.8960 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.9001 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.9170 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.9352 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.9381 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.9498 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.9519 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.9552 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.9578 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 0.9972 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0000 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0028 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0225 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0326 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0425 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0471 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0528 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0586 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0677 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0871 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0905 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.0963 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.1036 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.1394 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.1646 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.1671 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.1815 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.1901 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.1953 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.1992 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.1994 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.2004 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.2090 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.2140 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.2140 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.2742 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.3771 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.4468 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.4920 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.4974 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.5443 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.5524 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.6090 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.6197 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.6208 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.6494 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.6547 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.6725 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.7019 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.7150 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.7583 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.7671 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.8677 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.8678 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.9253 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.9526 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 1.9976 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.0104 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.0177 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.0286 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.0392 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.0405 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.0627 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.0828 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.1100 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.1373 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.2669 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.2674 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.2935 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.3166 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.5521 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.5582 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.5961 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.6205 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.6495 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.7165 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.9128 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.9224 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.9240 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.9316 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.9680 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 2.9857 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 3.0247 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 3.0435 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 3.2045 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 3.2579 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 3.4049 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 3.5263 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 3.5979 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 3.8957 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 3.9604 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 4.3068 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 4.7175 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 4.9993 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 5.9082 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 6.7004 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 7.2121 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 7.2184 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | taurochenodeoxycholate | 9.1420 | scaled units | Low-Dose | +23HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|